Awan FT, Yande S, Esterberg L, Nagar SP, Goyal RK, Priyadarshini M. Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): a SEER-Medicare analysis. Poster presented at the ASCO Quality Care Symposium 2023; October 27, 2023. Boston, MA. [abstract] JCO Oncol Pract. 2023 Nov 1; 19(11 Suppl):23-4. doi: 10.1200/OP.2023.19.11_suppl.24
Gnanasakthy A, Norcross L, Clark M, Fitzgerald K. A review of patient-reported outcome considerations in oncologic drug advisory committee meetings (2016-2021). JCO Oncol Pract. 2023 May;19(5):e745-62. doi: 10.1200/OP.22.00774
Mogle J, Hill NL, Bell TR, Bhargava S, Bratlee-Whitaker E, Wion RK, Tiwari PA. Combined influences of dementia exposure and personality on self-reported memory problems. Am J Alzheimers Dis Other Demen. 2020 Dec;35. doi: 10.1177/1533317519899792
Britt (DiBenedetti) DM, Adams, Jr SG, Gooding PR, Grothues CA, Varando P. Clinical differentiation of the Rey Auditory-Verbal Learning Test. Am J Alzheimers Dis Other Demen. 1995 Nov 1;10(6):7-18. doi: 10.1177/153331759501000603
Clarkson T, Anthony MS, Hughes C. Estrogenic soybean isoflavones and chronic disease: risks and benefits. Trends Endocrinol Metab. 1995 Jan;6(1):11-6.